Abstract:Abstract Natural killer (NK) cells were reported to be involved in the pathogenesis of primary antiphospholipid syndrome (pAPS). Immunosuppressive receptor TIGIT and activating receptor CD226 are specifically expressed on NK cells with competitive functions. This study aims to investigate the expression diversities of CD226/TIGIT on NK subsets and their associations with NK subsets activation phenotypes and potential clinical significance, furthermore, to explore potential cause for CD226/TIGIT expression diversities in pAPS. We comparatively assessed the changes of CD56brightNK, CD56dimNK and NK-like cells in seventy pAPS patients compared with control groups, including SLE, asymptomatic-carriers of aPLs, and healthy controls (HCs) and their expression diversities of CD226/TIGIT by flow cytometry. CD25, CD69, CD107α expression and IFN-γ secretion levels of NK subsets were detected to determine the potential association of CD226/TIGIT expression with NK subsets activation. CD226/TIGIT expression levels were compared among different subgroups divided by aPLs status. Moreover, in-vitro cultures were conducted to explore the potential mechanisms of CD226/TIGIT expression imbalance. Results: CD56brightNK and CD3+CD56+NK-like cells were significantly increased while CD56dimNK cells were obviously decreased in pAPS, and CD56brightNK and NK-like cells exhibited significantly higher CD226 but lower TIGIT expressions. CD226+CD56brightNK and TIGIT-CD56brightNK cells show higher CD69 expression and IFN-γ secretion capacity, and CD226+NK-like and TIGIT-NK-like cells showed higher expressions of CD25 and CD69 but lower apoptosis than CD226- and TIGIT+CD56brightNK/NK-like cells, respectively. The imbalanced CD226/TIGIT expressions were most significant in aPLs triple-positive group. Expression imbalanced of CD226/TIGIT on CD56brightNK and NK-like cells were aggravated after IL-4 stimulation and recovered after tofacitinib blocking. Conclusion: Our data revealed significant imbalanced CD226/TIGIT expressions on NK cells in pAPS, which closely associated with activated NK subsets phenotypes and more complicated autoantibody status. CD226/TIGIT imbalanced may be affected by IL-4/JAK pathway activation.

Downregulation of TIGIT Expression in FOXP3+Regulatory T Cells in Acute Coronary Syndrome

The Increased TIGIT-Expressing CD3+CD56+ Cells Are Associated with Coronary Artery Disease and Its Inflammatory Environment.

Characteristics, prognostic determinants of monocytes, macrophages and T cells in acute coronary syndrome: protocol for a multicenter, prospective cohort study

Ticagrelor and clopidogrel suppress NF-κB to treat acute coronary syndrome

Impaired thymic export and increased apoptosis account for regulatory T cell defects in patients with non-ST segment elevation acute coronary syndrome

Regulatory Effect of IL-10 on Expression of Tissue Factor Induced by IL-6 in Peripheral Blood Mononuclear Cells

Level of CD4~+ Foxp~(3+) Regulatory T Cells and Cytokines in Peripheral Blood of Patients with Coronary Heart Disease and Its Clinic Significance

Impairment of Circulating CD4⁺CD25⁺GARP⁺ regulatory T cells in patients with acute coronary syndrome

Longitudinal Variations in Th and Treg Cells Before and After Percutaneous Coronary Intervention, and Their Intercorrelations and Prognostic Value in Acute Syndrome Patients

Clonal restriction and predominance of regulatory T cells in coronary thrombi of patients with acute coronary syndromes

Cytotoxic T Lymphocyte Antigen-4 Down-Regulates T Helper 1 Cells by Increasing Expression of Signal Transducer and Activator of Transcription 3 in Acute Graft-versus-Host Disease.

Dynamic Changes of Th1/Th2 Subsets in Patients with Acute Coronary Syndrome

Expansion of T-cell receptor zeta dim effector T cells in acute coronary syndromes

Recovery of CD226-TIGIT+FoxP3+ and CD226-TIGIT-FoxP3+ Regulatory T Cells Contributes to Clinical Remission from Active Stage in Ulcerative Colitis Patients

TIGIT Regulates T Cell Inflammation in Airway Inflammatory Diseases

The correlation of tolerangenic TIGIT+NK cells with the severity of COPD

TIGIT regulates CD4+ T cell immunity against polymicrobial sepsis

Immune and Inflammation in Acute Coronary Syndrome: Molecular Mechanisms and Therapeutic Implications

Altered CD226/TIGIT expressions were associated with activated NK phenotypes in primary anti-phospholipid syndrome and affected by IL-4/JAK pathway

Regulatory T cell frequency and function in acute myocardial infarction patients and its correlation with ventricular dysfunction

Disregulated expression of co-stimulatory molecules PD-1 and CD28 on peripheral T lymphocytes in patients with acute coronary syndrome